As an example, a 3D‐nanopatterned microfluidic chip allowed for the detection, in 2‐μL plasma samples from ovarian cancer patients, of exosome subpopulations expressing CD24, EpCAM and FR‐α proteins as potential biomarkers for ovarian cancer.36 This evidence concerns the gene EPCAM and ovarian carcinoma.